Literature DB >> 22864921

MACH14: a multi-site collaboration on ART adherence among 14 institutions.

Honghu Liu1, Ira B Wilson, Kathy Goggin, Nancy Reynolds, Jane M Simoni, Carol E Golin, Marc I Rosen, Robert Gross, Glenn Wagner, Robert H Remien, Neil Schneiderman, Judith A Erlen, Julia H Arnsten, David R Bangsberg.   

Abstract

The integration of original data from multiple antiretroviral (ARV) adherence studies offers a promising, but little used method to generate evidence to advance the field. This paper provides an overview of the design and implementation of MACH14, a collaborative, multi-site study in which a large data system has been created for integrated analyses by pooling original data from 16 longitudinal ARV adherence studies. Studies selected met specific criteria including similar research design and data domains such as adherence measured with medication event monitoring system, psychosocial factors related to adherence behavior, and virologic and clinical outcomes. The data system created contains individual data (collected between 1997 and 2009) from 2,860 HIV patients. Collaboration helped resolve the challenges inherent in pooling data across multiple studies, yet produced a data system with strong statistical power and potentially greater capacity to address key scientific questions than possible with single-sample studies or even meta-analytic designs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22864921      PMCID: PMC3769091          DOI: 10.1007/s10461-012-0272-4

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  26 in total

1.  Treatment outcomes after highly active antiretroviral therapy: a meta-analysis of randomised controlled trials.

Authors:  Wayne T A Enanoria; Cherie Ng; Sona R Saha; John M Colford
Journal:  Lancet Infect Dis       Date:  2004-07       Impact factor: 25.071

2.  Adherence to antiretroviral medications in HIV: differences in data collected via self-report and electronic monitoring.

Authors:  Andrew J Levine; Charles H Hinkin; Sarah Marion; Allison Keuning; Steven A Castellon; Mona M Lam; Marta Robinet; Douglas Longshore; Thomas Newton; Hector Myers; Ramani S Durvasula
Journal:  Health Psychol       Date:  2006-05       Impact factor: 4.267

3.  Repeated measures longitudinal analyses of HIV virologic response as a function of percent adherence, dose timing, genotypic sensitivity, and other factors.

Authors:  Honghu Liu; Loren G Miller; Ron D Hays; Carol E Golin; Tongtong Wu; Neil S Wenger; Andrew H Kaplan
Journal:  J Acquir Immune Defic Syndr       Date:  2006-03       Impact factor: 3.731

4.  Advanced statistics: missing data in clinical research--part 2: multiple imputation.

Authors:  Craig D Newgard; Jason S Haukoos
Journal:  Acad Emerg Med       Date:  2007-07       Impact factor: 3.451

5.  The relative benefits of meta-analysis conducted with individual participant data versus aggregated data.

Authors:  Harris Cooper; Erika A Patall
Journal:  Psychol Methods       Date:  2009-06

6.  Meta-analysis of individual patient data versus aggregate data from longitudinal clinical trials.

Authors:  Ashley P Jones; Richard D Riley; Paula R Williamson; Anne Whitehead
Journal:  Clin Trials       Date:  2009-02       Impact factor: 2.486

7.  Lessons learned from an HIV adherence pilot study in the Deep South.

Authors:  Deborah J Konkle-Parker; Judith A Erlen; Patricia M Dubbert
Journal:  Patient Educ Couns       Date:  2009-06-26

8.  Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale.

Authors:  Thomas P Giordano; David Guzman; Richard Clark; Edwin D Charlebois; David R Bangsberg
Journal:  HIV Clin Trials       Date:  2004 Mar-Apr

9.  Predictors of antiretroviral adherence as measured by self-report, electronic monitoring, and medication diaries.

Authors:  Glenn J Wagner
Journal:  AIDS Patient Care STDS       Date:  2002-12       Impact factor: 5.078

10.  Efavirenz versus nevirapine-based initial treatment of HIV infection: clinical and virological outcomes in Southern African adults.

Authors:  Jean B Nachega; Michael Hislop; David W Dowdy; Joel E Gallant; Richard E Chaisson; Leon Regensberg; Gary Maartens
Journal:  AIDS       Date:  2008-10-18       Impact factor: 4.177

View more
  11 in total

1.  Racial/Ethnic disparities in ART adherence in the United States: findings from the MACH14 study.

Authors:  Jane M Simoni; David Huh; Ira B Wilson; Jie Shen; Kathy Goggin; Nancy R Reynolds; Robert H Remien; Marc I Rosen; David R Bangsberg; Honghu Liu
Journal:  J Acquir Immune Defic Syndr       Date:  2012-08-15       Impact factor: 3.731

2.  A closer look at depression and its relationship to HIV antiretroviral adherence.

Authors:  Glenn J Wagner; Kathy Goggin; Robert H Remien; Marc I Rosen; Jane Simoni; David R Bangsberg; Honghu Liu
Journal:  Ann Behav Med       Date:  2011-12

3.  Association between use of specific drugs and antiretroviral adherence: findings from MACH 14.

Authors:  M I Rosen; A C Black; J H Arnsten; K Goggin; R H Remien; J M Simoni; C E Golin; D R Bangsberg; H Liu
Journal:  AIDS Behav       Date:  2013-01

4.  Super Learner Analysis of Electronic Adherence Data Improves Viral Prediction and May Provide Strategies for Selective HIV RNA Monitoring.

Authors:  Maya L Petersen; Erin LeDell; Joshua Schwab; Varada Sarovar; Robert Gross; Nancy Reynolds; Jessica E Haberer; Kathy Goggin; Carol Golin; Julia Arnsten; Marc I Rosen; Robert H Remien; David Etoori; Ira B Wilson; Jane M Simoni; Judith A Erlen; Mark J van der Laan; Honghu Liu; David R Bangsberg
Journal:  J Acquir Immune Defic Syndr       Date:  2015-05-01       Impact factor: 3.731

5.  The association between poor antiretroviral adherence and unsafe sex: differences by gender and sexual orientation and implications for scale-up of treatment as prevention.

Authors:  Robert H Remien; Curtis Dolezal; Glenn J Wagner; Kathy Goggin; Ira B Wilson; Robert Gross; Marc I Rosen; Jie Shen; Jane M Simoni; Carol E Golin; Julia H Arnsten; David R Bangsberg; Honghu Liu
Journal:  AIDS Behav       Date:  2014-08

6.  Cost of behavioral interventions utilizing electronic drug monitoring for antiretroviral therapy adherence.

Authors:  Rafia S Rasu; David F Malewski; Julie W Banderas; Domonique Malomo Thomson; Kathy Goggin
Journal:  J Acquir Immune Defic Syndr       Date:  2013-05-01       Impact factor: 3.731

7.  Validity of behavioral measures as proxies for HIV-related outcomes.

Authors:  Rick S Zimmerman; Donald E Morisky; Lana Harrison; Hayley D Mark
Journal:  J Acquir Immune Defic Syndr       Date:  2014-08-15       Impact factor: 3.731

8.  The validity of self-reported medication adherence as an outcome in clinical trials of adherence-promotion interventions: Findings from the MACH14 study.

Authors:  Jane M Simoni; David Huh; Yan Wang; Ira B Wilson; Nancy R Reynolds; Robert H Remien; Kathy Goggin; Robert Gross; Marc I Rosen; Neil Schneiderman; Julia Arnsten; Carol E Golin; Judith A Erlen; David R Bangsberg; Honghu Liu
Journal:  AIDS Behav       Date:  2014-12

9.  Assessing usual care in clinical trials.

Authors:  Judith A Erlen; Lisa K Tamres; Nancy Reynolds; Carol E Golin; Marc I Rosen; Robert H Remien; Julie W Banderas; Neil Schneiderman; Glenn Wagner; David R Bangsberg; Honghu Liu
Journal:  West J Nurs Res       Date:  2014-03-12       Impact factor: 1.967

10.  Heterogeneity among studies in rates of decline of antiretroviral therapy adherence over time: results from the multisite adherence collaboration on HIV 14 study.

Authors:  Ira B Wilson; David R Bangsberg; Jie Shen; Jane M Simoni; Nancy R Reynolds; Kathy Goggin; Robert Gross; Julia H Arnsten; Robert H Remien; Judith A Erlen; Honghu Liu
Journal:  J Acquir Immune Defic Syndr       Date:  2013-12-15       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.